- Improved liquid-chromatography of aspirin, salicylate, and salicyluric acid in plasma, with a modification for determining aspirin metabolites in urine.
Improved liquid-chromatography of aspirin, salicylate, and salicyluric acid in plasma, with a modification for determining aspirin metabolites in urine.
Clinical chemistry (1982-05-01)
J N Buskin, R A Upton, R L Williams
PMID7074905
ABSTRACT
Detailed performance specifications are given for a specific and sensitive liquid-chromatographic assay for aspirin, salicylic acid, and salicyluric acid in plasma. The sensitivity of this method for aspirin (50 micrograms/L) is 10-fold that of previous methods, so that concentrations of aspirin in plasma can now be followed for about four or five half-lives after the peak plasma concentration arising from a single 650-mg dose. In addition, this assay is as sensitive for salicylic and salicyluric acid in plasma as any hitherto. A modification permits measurement of gentisic acid, salicylic acid, and salicyluric acid in urine; further modifications allow indirect measurement of conjugated gentisate and salicylate in urine.
MATERIALS
Product Number
Brand
Product Description
Pricing and availability is not currently available.
Pricing and availability is not currently available.
Supelco
2,5-Dihydroxybenzoic acid, suitable for matrix substance for MALDI-MS, ≥99.5% (HPLC), Ultra pure
Pricing and availability is not currently available.